Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Meridian Bioscience Inc (NASDAQ:VIVO)

15.50
Delayed Data
As of 4:00pm ET
 +0.15 / +0.98%
Today’s Change
10.75
Today|||52-Week Range
20.50
-12.43%
Year-to-Date
MedTech Industry Outlook - July 2017
Jul 06 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close15.35
Today’s open15.40
Day’s range15.30 - 15.55
Volume321,148
Average volume (3 months)306,813
Market cap$647.8M
Dividend yield3.23%
Data as of 4:00pm ET, 07/20/2017

Growth & Valuation

Earnings growth (last year)-10.59%
Earnings growth (this year)-15.36%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.64%
P/E ratio21.8
Price/Sales4.17
Price/Book3.88

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...+0.10+0.54%
ALRPRBAlere Inc+1.44+0.36%
CALACalithera Bioscience...-0.45-2.76%
OXFDOxford Immunotec Glo...-0.24-1.44%
Data as of 4:00pm ET, 07/20/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$0.17
Annual revenue (last year)$196.1M
Annual profit (last year)$32.2M
Net profit margin16.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John A. Kraeutler
President &
Chief Commercial Officer
Richard L. Eberly
Corporate headquarters
Cincinnati, Ohio

Forecasts